In conclusion, RNA biomarkers showed better clinical utility to guide confirmatory TB testing for pre-ART screening than W4SS, but their performance did not exceed that of CRP, and fell short of WHO mandated targets. The gene discussed is CRP; the disease is tuberculosis.